Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Arena Pharmaceuticals)"
Count: 26
Selected: 0
NCT IDTitle
NCT04915950A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis
NCT04848220A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
NCT04706793Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)
NCT04682639A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
NCT04655599Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
NCT04607837Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
NCT04556734Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata
NCT04173273A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
NCT04162769A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
NCT04043455Olorinab in IBS-C and IBS-D
NCT03996369Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
NCT03950232An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
NCT03945188Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
NCT03155945Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects With Crohn's Disease Experiencing Abdominal Pain
NCT03155932Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis
NCT03139032Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations
NCT03072953Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum
NCT02536404Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
NCT02447302Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
NCT02044874A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
NCT01093508Single-dose Safety Study of APD916 in Healthy Volunteers
NCT00664664Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia
NCT00619931A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers
NCT00529646Single-Dose Safety Study of APD791 in Healthy Volunteers
NCT00452179Safety and Efficacy Study of APD125 in Patient With Insomnia
NCT05033340The Efficacy and Safety of Oral Etrasimod as Therapy for Moderately to Severely Active Crohn's Disease